Back

Pharmacotherapy to reduce weight in patients with HFpEF and obesity: what is the latest evidence?

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Weight loss as a therapeutic target in HFpEF: dawn of a new era? Chronic Heart Failure ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)

4 More presentations in this session

Presentation thumbnail
Fat accumulation in the musculature in HFpEF: role for exercise intolerance?
Professor M. Haykowsky (Edmonton, CA)
Slides Video
Presentation thumbnail
Caloric restriction and structured exercise programmes in HFpEF: do they improve symptoms and functional status?
Doctor M. Lee (Glasgow, GB)
Slides Video
Presentation thumbnail
Bariatric surgery to manage obesity in patients with HFpEF
Professor D. Dicker (Petah Tikva, IL)
Slides Video
Presentation thumbnail
Weight loss as a therapeutic target in HFpEF: dawn of a new era? - discussion
Video

Access the full session

Session thumbnail
Weight loss as a therapeutic target in HFpEF: dawn of a new era?
Video

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Congress Presentation
Presence of heart failure in pts with coronary artery disease and artery hypertension
thumbnail
Congress Presentation
Non-conventional parameters from holter ECG: a promising tool for heart failure risk stratification

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources